Quote: from Ohm20 But that's the dilemma for big

New Post Public Reply Private Reply Replies (3) Message Board
Goosebumps ohm20 #99356
631
Quote: from Ohm20


But that's the dilemma for big pharma, can they make a buyout offer small enough to not put their shareholders in revolt and big enough that Cytodyn's shareholders would vote yes. I don't think they can. After first approval for Cytodyn gets first approval a buyout is completely thrown out the window.

I just have to agree with this comment. I feel it is beyond the truth and it’s more likely prophetic and can’t agree more. After reading this I was trying to rapid fire my thumbs up tab like it was a video game but to no avail.

Thanks Ohm for the reassurance that we are well on our way to our own Big Pharma… I don’t see it any other way. I was considering aways the companies plan last year when the annual shareholders meeting produced the plan to become our own Pharmaceutical company. Then to trial 10 indications a year with the most life saving indications first. The beauty of this is… life saving is big money and the most revenue producing of the indications. This produces the largest results in Stock price the fastest also.

It will be like an explosion when we get our first 5 approvals and they just all happen to be major Block Busters in Revenue… mTNBC, Cancer basket trial, Covid LH’ers, Nash and HIV and then throw in the two Brazil severe/critical or better known now as Moderate/ Critical for a lucky 7. If we are opportunistic enough to realize a market for each indication in just these few indications… how can we not be over 3 digits inside of a year after completing these approvals and maybe mid 3 digits. I always believed in this SP going ballistic. Getting all of just these indications approved may take up to two years but it going to be a hell of a ride getting there!!! After the first one and a safety profile is accepted. The others will come quicker and quicker. Now that the fear of the stupid 13d slime balls is gone… we can relax and look forward to a great ride in my opinion.


Read More: https://investorshangout.com/post/newpost/605...z7341ZpfiO

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 3

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
CME Group Smashes FX Open Interest Record Again

Updated Category News Views 4

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

Continue Reading
AB SKF to Hold EGM, Spin Off Automotive Assets

Updated Category News Views 5

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

Continue Reading
Universal Music Wraps €250M Share Buyback Plan

Updated Category News Views 1

Universal's Encore Performance in the Markets Universal Music Group (EURONEXT: UMG), the behemoth in music-based entertainment, just wrapped up its €250 million share buyback program. Talk about a grand finale! In a week’s worth of maneuvering from August 31 to September 4, they snagged 294,340 of their own shares, all for the pretty price of €14.65 a pop. Grand...

Continue Reading
Early Orders Key for Custom Kids' Gifts This Season

Updated Category News Views 2

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Continue Reading
AXIS-Y: Global Expansion Fueled by KRW 430B Valuation

Updated Category News Views 4

Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...

Continue Reading
Sony Expands Versatile Wireless Headphone Lineup: 2026

Updated Category News Views 4

Renewed Focus on Sound: Sony's Latest Headphones Sony's dipping into the headphone market this time with a splash of style and sound signature updates. We've got the WH-1000XM4C, a next-gen version of the top-dog noise-cancelling cans, that are gonna catch the eye of every audiophile and traveler out there. WH-1000XM4C: The Flagship gets a Lift What they're offering is...

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 2

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading
Thermoplastic Polyimide: A $0.86 Billion Market by 2032

Updated Category News Views 3

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

Continue Reading
Interventional Ophthalmology: Early Eye Care Strategies Evolve

Updated Category News Views 2

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Kitchen Solution: TASTE TESTERS for Hassle-Free Cooking

Updated Category News Views 122

Introducing TASTE TESTERS: A Kitchen Revolution Cooking can be a delightful experience, but it often calls for tasting food to ensure the flavors are just right. The inventor behind TASTE TESTERS has addressed this need by creating a set of utensils specifically designed for taste testing. Unlike typical kitchen tools that are primarily used for serving or mixing, these...

Continue Reading
iRobot's Upcoming Earnings Call: What to Expect in 2024

Updated Category News Views 219

iRobot Schedules Earnings Conference Call for 2024 iRobot Corp. (NASDAQ: IRBT), an innovator in consumer robotics and smart home technologies, has announced its plan to host its fourth-quarter and full-year 2024 earnings conference call. This call will take place on an upcoming Wednesday in March, a much-anticipated event for investors and stakeholders. Key Details of the...

Continue Reading
Grid Dynamics Achieves 52-Week High Amid Growth Initiatives

Updated Category News Views 78

Grid Dynamics Hits New Milestone In an impressive display of market strength, Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) has recently achieved a remarkable 52-week high, with stock trading at $14.72. This surge reflects a significant upward trend in the company’s performance over the preceding year. Investors have expressed increasing confidence in the digital...

Continue Reading
Banco Comercial Português Unveils New Share Allocation Plan

Updated Category News Views 172

Understanding Share Allocation at Banco Comercial Português Banco Comercial Português, S.A. has taken a significant step by announcing the share allocation plan as part of its strategy for variable remuneration directed towards individuals in managing roles. This policy aims to align the interests of management with those of shareholders, ultimately promoting long-term...

Continue Reading
ProMIS Neurosciences Pursues Financing for Neurodegenerative Solutions

Updated Category News Views 169

ProMIS Neurosciences Proceeds With Private Placement Financing ProMIS Neurosciences, Inc. (NASDAQ: PMN), a clinical-stage biotechnology enterprise dedicated to innovative therapeutic solutions, is on an exciting path of growth. This past July, the company announced a private investment initiative, aiming to raise approximately $2.4 million through warrants. These Warrants...

Continue Reading